Cargando…
Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection
Lentiviral vector–based dendritic cell vaccines induce protective T cell responses against viral infection and cancer in animal models. In this study, we tested whether preventative and therapeutic vaccination could be achieved by direct injection of antigen-expressing lentiviral vector, obviating t...
Autores principales: | Tada, Takuya, Norton, Thomas D., Leibowitz, Rebecca, Landau, Nathaniel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675446/ https://www.ncbi.nlm.nih.gov/pubmed/35972807 http://dx.doi.org/10.1172/jci.insight.161598 |
Ejemplares similares
-
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
por: Nemirov, Kirill, et al.
Publicado: (2023) -
Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
por: Fontana, Judith M., et al.
Publicado: (2014) -
Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
por: Tada, Takuya, et al.
Publicado: (2023) -
A Nonintegrative Lentiviral Vector-Based Vaccine Provides Long-Term Sterile Protection against Malaria
por: Coutant, Frédéric, et al.
Publicado: (2012) -
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model
por: Tada, Takuya, et al.
Publicado: (2023)